Combination HIV prevention: the value and interpretation of mathematical models
- PMID: 23797377
- PMCID: PMC3784635
- DOI: 10.1007/s11904-013-0167-7
Combination HIV prevention: the value and interpretation of mathematical models
Abstract
Mathematical models of HIV prevention interventions often provide critical insights related to programmatic design and economic efficiency. One recent dynamic model by Long et al. highlights that a combination prevention approach - with testing, treatment, circumcision, microbicides and PrEP - may decrease transmissions by over 60% and may be very cost-effective in South Africa. In this analysis, the authors introduce the critical concept of joint effectiveness of preventions programs and demonstrate how some programs operate synergistically (HIV screening coupled with early treatment) while others may create redundancies (microbicides coupled with pre-exposure prophylaxis). Whether combination HIV prevention programs perform with additive, multiplicative or maximal effectiveness will be important to consider in anticipation of their combined transmission impact.
Conflict of interest statement
Rochelle P. Walensky has been a consultant for Le Clair Ryan.
Similar articles
-
Portfolios of biomedical HIV interventions in South Africa: a cost-effectiveness analysis.J Gen Intern Med. 2013 Oct;28(10):1294-301. doi: 10.1007/s11606-013-2417-1. Epub 2013 Apr 16. J Gen Intern Med. 2013. PMID: 23588668 Free PMC article.
-
Dapivirine vaginal ring for HIV prevention: modelling health outcomes, drug resistance and cost-effectiveness.J Int AIDS Soc. 2019 May;22(5):e25282. doi: 10.1002/jia2.25282. J Int AIDS Soc. 2019. PMID: 31074936 Free PMC article.
-
Epidemiological impact and cost-effectiveness of providing long-acting pre-exposure prophylaxis to injectable contraceptive users for HIV prevention in South Africa: a modelling study.J Int AIDS Soc. 2019 Dec;22(12):e25427. doi: 10.1002/jia2.25427. J Int AIDS Soc. 2019. PMID: 31855323 Free PMC article.
-
Cost-effectiveness of pre-exposure prophylaxis for HIV: a review.Curr Opin HIV AIDS. 2012 Nov;7(6):587-92. doi: 10.1097/COH.0b013e3283582c8b. Curr Opin HIV AIDS. 2012. PMID: 23076124 Review.
-
Combining biomedical preventions for HIV: Vaccines with pre-exposure prophylaxis, microbicides or other HIV preventions.Hum Vaccin Immunother. 2016 Dec;12(12):3202-3211. doi: 10.1080/21645515.2016.1231258. Hum Vaccin Immunother. 2016. PMID: 27679928 Free PMC article. Review.
Cited by
-
Accounting for historical injustices in mathematical models of infectious disease transmission: An analytic overview.Epidemics. 2023 Jun;43:100679. doi: 10.1016/j.epidem.2023.100679. Epub 2023 Mar 11. Epidemics. 2023. PMID: 36924757 Free PMC article.
-
Thirty years of the human immunodeficiency virus epidemic and beyond.Int J Oral Sci. 2013 Dec;5(4):191-9. doi: 10.1038/ijos.2013.76. Epub 2013 Oct 18. Int J Oral Sci. 2013. PMID: 24136672 Free PMC article. Review.
-
Infectious Disease Modelling of HIV Prevention Interventions: A Systematic Review and Narrative Synthesis of Compartmental Models.Pharmacoeconomics. 2023 Jun;41(6):693-707. doi: 10.1007/s40273-023-01260-z. Epub 2023 Mar 29. Pharmacoeconomics. 2023. PMID: 36988896 Free PMC article.
-
HIV Prevention Interventions for Adolescents.Curr HIV/AIDS Rep. 2019 Feb;16(1):120-128. doi: 10.1007/s11904-019-00431-y. Curr HIV/AIDS Rep. 2019. PMID: 30707399 Free PMC article. Review.
References
-
- Marseille E, Hofmann PB, Kahn JG. HIV prevention before HAART in sub-Saharan Africa. Lancet. 2002;359(9320):1851–6. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous